Shorts

ALLEGORY: Expanding Obinutuzmab to SLE

Hidden Inequities in Lupus Care and Steroid Use

Why Does ICI-Induced Inflammatory Arthritis Persist?

CAR T's Place in Lupus Treatment

A Vicious Cycle: Obesity and Autoimmune Disease

GLP-1's Benefit for Osteoarthritis

Favorable Benefit-Risk Profile With Osteoporosis Prevention

Imaging Advances in Vasculitis

Shifting Attention to Difficult-to-Treat PsA and AxSpA

Evolving our Understanding of Lupus

SLE Treatment Choices: Subcutaneous or Intravenous?

The Promise of TYK2 Inhibition for PSA